BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14644505)

  • 1. Chimeric transcriptional control units for improved liver-specific transgene expression.
    Gehrke S; Jérôme V; Müller R
    Gene; 2003 Dec; 322():137-43. PubMed ID: 14644505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of transcriptional regulatory elements for constructing plasmid vectors.
    Xu ZL; Mizuguchi H; Ishii-Watabe A; Uchida E; Mayumi T; Hayakawa T
    Gene; 2001 Jul; 272(1-2):149-56. PubMed ID: 11470520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo comparative study of chimeric liver-specific promoters.
    Kramer MG; Barajas M; Razquin N; Berraondo P; Rodrigo M; Wu C; Qian C; Fortes P; Prieto J
    Mol Ther; 2003 Mar; 7(3):375-85. PubMed ID: 12668133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An enhancer element 6 kb upstream of the mouse HNF4alpha1 promoter is activated by glucocorticoids and liver-enriched transcription factors.
    Bailly A; Torres-Padilla ME; Tinel AP; Weiss MC
    Nucleic Acids Res; 2001 Sep; 29(17):3495-505. PubMed ID: 11522818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Improvement of transcriptional activity of hTERT promoter by SV40 enhancer].
    Zhang WM; Xue LY; Xu Y; Xing J; Geng X; Wang D; Li YY
    Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):691-3. PubMed ID: 17374218
    [No Abstract]   [Full Text] [Related]  

  • 6. An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas.
    Lam PY; Sia KC; Khong JH; De Geest B; Lim KS; Ho IA; Wang GY; Miao LV; Huynh H; Hui KM
    Mol Ther; 2007 Jun; 15(6):1129-36. PubMed ID: 17426711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
    Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
    J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue specificity of L-pyruvate kinase transgenes results from the combinatorial effect of proximal promoter and distal activator regions.
    Miquerol L; Cluzeaud F; Porteu A; Alexandre Y; Vandewalle A; Kahn A
    Gene Expr; 1996; 5(6):315-30. PubMed ID: 8836739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain.
    Liu BH; Yang Y; Paton JF; Li F; Boulaire J; Kasparov S; Wang S
    Mol Ther; 2006 Dec; 14(6):872-82. PubMed ID: 16904943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol and bile acids regulate cholesterol 7 alpha-hydroxylase expression at the transcriptional level in culture and in transgenic mice.
    Ramirez MI; Karaoglu D; Haro D; Barillas C; Bashirzadeh R; Gil G
    Mol Cell Biol; 1994 Apr; 14(4):2809-21. PubMed ID: 8139578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo.
    Riu E; Grimm D; Huang Z; Kay MA
    Hum Gene Ther; 2005 May; 16(5):558-70. PubMed ID: 15916481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer.
    Guo ZS; Wang LH; Eisensmith RC; Woo SL
    Gene Ther; 1996 Sep; 3(9):802-10. PubMed ID: 8875229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulators prevent transcriptional interference between two promoters in a double gene construct for transgenesis.
    Hasegawa K; Nakatsuji N
    FEBS Lett; 2002 Jun; 520(1-3):47-52. PubMed ID: 12044868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector.
    Argyros O; Wong SP; Niceta M; Waddington SN; Howe SJ; Coutelle C; Miller AD; Harbottle RP
    Gene Ther; 2008 Dec; 15(24):1593-605. PubMed ID: 18633447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte-specific gene expression from integrated lentiviral vectors.
    Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
    J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of gene structures and promoter activities of the chipmunk alpha(1)-antitrypsin-like genes.
    Nakazawa A; Inaba Y; Kamijima A; Kondo N; Ito M; Shiba T; Takamatsu N
    Gene; 2004 Mar; 329():71-9. PubMed ID: 15033530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tissue-specific promoters and microRNA recognition elements on stability of transgene expression after hydrodynamic naked plasmid DNA delivery.
    Wolff LJ; Wolff JA; Sebestyén MG
    Hum Gene Ther; 2009 Apr; 20(4):374-88. PubMed ID: 19199823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX.
    Schüttrumpf J; Milanov P; Abriss D; Roth S; Tonn T; Seifried E
    Hum Gene Ther; 2011 Jan; 22(1):101-6. PubMed ID: 20677911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNF3beta and GATA-4 transactivate the liver-enriched homeobox gene, Hex.
    Denson LA; McClure MH; Bogue CW; Karpen SJ; Jacobs HC
    Gene; 2000 Apr; 246(1-2):311-20. PubMed ID: 10767553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of viral and mammalian promoters for driving transgene expression in mouse liver.
    Al-Dosari M; Zhang G; Knapp JE; Liu D
    Biochem Biophys Res Commun; 2006 Jan; 339(2):673-8. PubMed ID: 16316630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.